A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics

Here, we randomized 53 patients hospitalized with coronavirus disease 2019 (COVID-19) to hydroxychloroquine therapy (at a dose of 400 mg twice daily for seven days) in addition to standard care or standard care alone (ClinicalTrials.gov Identifier, NCT04316377). All severe acute respiratory syndrome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Lyngbakken, Magnus Nakrem, Berdal, Jan-Erik, Eskesen, Arne, Kvale, Dag, Olsen, Inge Christoffer, Rueegg, Corina Silvia, Rangberg, Anbjørg, Jonassen, Christine Monceyron, Omland, Torbjørn, Røsjø, Helge, Dalgard, Olav
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576792/
https://ncbi.nlm.nih.gov/pubmed/33082342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19056-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados